- Home
- ELDN vs SNDL Comparison
ELDN vs SNDL Comparison
Compare ELDN & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELDN | SNDL |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.8M | 312.4M |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ELDN | SNDL |
|---|---|---|
| Price | $3.54 | $1.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.50 | $5.00 |
| AVG Volume (30 Days) | 910.2K | ★ 1.9M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.19 |
| Revenue Next Year | N/A | $3.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $1.17 |
| 52 Week High | $4.60 | $2.89 |
Technical Indicators
Market Signals| Indicator | ELDN | SNDL |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 48.64 |
| Support Level | $3.31 | $1.17 |
| Resistance Level | $4.17 | $1.37 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 46.40 | 70.37 |
Price Performance
Historical ComparisonAbout ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.